170 related articles for article (PubMed ID: 29229294)
1. Impact of DHA intake in a mouse model of synucleinopathy.
Coulombe K; Kerdiles O; Tremblay C; Emond V; Lebel M; Boulianne AS; Plourde M; Cicchetti F; Calon F
Exp Neurol; 2018 Mar; 301(Pt A):39-49. PubMed ID: 29229294
[TBL] [Abstract][Full Text] [Related]
2. Effect of Docosahexaenoic Acid (DHA) at the Enteric Level in a Synucleinopathy Mouse Model.
Lamontagne-Proulx J; Coulombe K; Dahhani F; Côté M; Guyaz C; Tremblay C; Di Marzo V; Flamand N; Calon F; Soulet D
Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959768
[TBL] [Abstract][Full Text] [Related]
3. A30P α-synuclein impairs dopaminergic fiber regeneration and interacts with L-DOPA replacement in MPTP-treated mice.
Szego ÉM; Gerhardt E; Kermer P; Schulz JB
Neurobiol Dis; 2012 Jan; 45(1):591-600. PubMed ID: 22001606
[TBL] [Abstract][Full Text] [Related]
4. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
5. Impact of dietary n-3 polyunsaturated fatty acids on cognition, motor skills and hippocampal neurogenesis in developing C57BL/6J mice.
Janssen CI; Zerbi V; Mutsaers MP; de Jong BS; Wiesmann M; Arnoldussen IA; Geenen B; Heerschap A; Muskiet FA; Jouni ZE; van Tol EA; Gross G; Homberg JR; Berg BM; Kiliaan AJ
J Nutr Biochem; 2015 Jan; 26(1):24-35. PubMed ID: 25444517
[TBL] [Abstract][Full Text] [Related]
6. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice.
Schell H; Hasegawa T; Neumann M; Kahle PJ
Neuroscience; 2009 Jun; 160(4):796-804. PubMed ID: 19272424
[TBL] [Abstract][Full Text] [Related]
7. Abnormal colonic motility in mice overexpressing human wild-type alpha-synuclein.
Wang L; Fleming SM; Chesselet MF; Taché Y
Neuroreport; 2008 May; 19(8):873-6. PubMed ID: 18463504
[TBL] [Abstract][Full Text] [Related]
8. Motor impairment and aberrant production of neurochemicals in human alpha-synuclein A30P+A53T transgenic mice with alpha-synuclein pathology.
Ikeda M; Kawarabayashi T; Harigaya Y; Sasaki A; Yamada S; Matsubara E; Murakami T; Tanaka Y; Kurata T; Wuhua X; Ueda K; Kuribara H; Ikarashi Y; Nakazato Y; Okamoto K; Abe K; Shoji M
Brain Res; 2009 Jan; 1250():232-41. PubMed ID: 18992718
[TBL] [Abstract][Full Text] [Related]
9. Dietary fish oil n-3 polyunsaturated fatty acids and alpha-linolenic acid differently affect brain accretion of docosahexaenoic acid and expression of desaturases and sterol regulatory element-binding protein 1 in mice.
Zhu H; Fan C; Xu F; Tian C; Zhang F; Qi K
J Nutr Biochem; 2010 Oct; 21(10):954-60. PubMed ID: 19954955
[TBL] [Abstract][Full Text] [Related]
10. Intracranial administration of alpha-synuclein fibrils in A30P-synuclein transgenic mice causes robust synucleinopathy and microglial induction.
Gentzel RC; Toolan D; Jinn S; Schachter JB; Ma L; Kahle PJ; Smith SM; Marcus JN
Neurobiol Aging; 2021 Oct; 106():12-25. PubMed ID: 34225000
[TBL] [Abstract][Full Text] [Related]
11. Sex and Age Differences in a Progressive Synucleinopathy Mouse Model.
Lamontagne-Proulx J; Coulombe K; Morissette M; Rieux M; Calon F; Di Paolo T; Soulet D
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371557
[TBL] [Abstract][Full Text] [Related]
12. Age-dependent cognitive decline and amygdala pathology in alpha-synuclein transgenic mice.
Freichel C; Neumann M; Ballard T; Müller V; Woolley M; Ozmen L; Borroni E; Kretzschmar HA; Haass C; Spooren W; Kahle PJ
Neurobiol Aging; 2007 Sep; 28(9):1421-35. PubMed ID: 16872721
[TBL] [Abstract][Full Text] [Related]
13. alpha-Synucleinopathy models and human neuropathology: similarities and differences.
Kahle PJ
Acta Neuropathol; 2008 Jan; 115(1):87-95. PubMed ID: 17932682
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of iron modulating drugs in a mouse model of multiple system atrophy.
Shukla JJ; Stefanova N; Bush AI; McColl G; Finkelstein DI; McAllum EJ
Neurobiol Dis; 2021 Nov; 159():105509. PubMed ID: 34537326
[TBL] [Abstract][Full Text] [Related]
15. Partial neurorescue effects of DHA following a 6-OHDA lesion of the mouse dopaminergic system.
Coulombe K; Saint-Pierre M; Cisbani G; St-Amour I; Gibrat C; Giguère-Rancourt A; Calon F; Cicchetti F
J Nutr Biochem; 2016 Apr; 30():133-42. PubMed ID: 27012630
[TBL] [Abstract][Full Text] [Related]
16. Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease.
Shchepinov MS; Chou VP; Pollock E; Langston JW; Cantor CR; Molinari RJ; Manning-Boğ AB
Toxicol Lett; 2011 Nov; 207(2):97-103. PubMed ID: 21906664
[TBL] [Abstract][Full Text] [Related]
17. Behavioral Deficits and Brain α-Synuclein and Phosphorylated Serine-129 α-Synuclein in Male and Female Mice Overexpressing Human α-Synuclein.
Gabrielyan L; Liang H; Minalyan A; Hatami A; John V; Wang L
J Alzheimers Dis; 2021; 79(2):875-893. PubMed ID: 33361597
[TBL] [Abstract][Full Text] [Related]
18. Immunolocalization of human alpha-synuclein in the Thy1-aSyn ("Line 61") transgenic mouse line.
Delenclos M; Carrascal L; Jensen K; Romero-Ramos M
Neuroscience; 2014 Sep; 277():647-64. PubMed ID: 25090921
[TBL] [Abstract][Full Text] [Related]
19. Social Cognition Impairments in Mice Overexpressing Alpha-Synuclein Under the Thy1 Promoter, a Model of Pre-manifest Parkinson's Disease.
Magen I; Torres ER; Dinh D; Chung A; Masliah E; Chesselet MF
J Parkinsons Dis; 2015; 5(3):669-680. PubMed ID: 25588356
[TBL] [Abstract][Full Text] [Related]
20. Chronic exposure to manganese decreases striatal dopamine turnover in human alpha-synuclein transgenic mice.
Peneder TM; Scholze P; Berger ML; Reither H; Heinze G; Bertl J; Bauer J; Richfield EK; Hornykiewicz O; Pifl C
Neuroscience; 2011 Apr; 180():280-92. PubMed ID: 21333719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
